These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6753393)

  • 61. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 62. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 63. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 64. [Results of a study with the antihypertensive agent Torrat].
    Werning C
    Ther Ggw; 1978 Dec; 117(12):1924-9. PubMed ID: 31703
    [No Abstract]   [Full Text] [Related]  

  • 65. [Antihypertensive therapy in young hypertensive patients. Effect of tredalat in comparison with adalat on blood pressure behavior and metabolism, especially renin excretion].
    Klimm HD; Voigt ED
    Fortschr Med; 1988 Feb; 106(6):118-22. PubMed ID: 3286427
    [No Abstract]   [Full Text] [Related]  

  • 66. [Bupranolol eye-drops (Ophtorenin) in long-term therapy of glaucoma (author's transl)].
    Stiegler G
    Klin Monbl Augenheilkd; 1979 Feb; 174(2):267-75. PubMed ID: 439706
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 68. The antihypertensive effect of cyclothiazide, a double blind study.
    Antlitz AM; Valle NG
    Curr Ther Res Clin Exp; 1967 Jun; 9(6):288-92. PubMed ID: 4963064
    [No Abstract]   [Full Text] [Related]  

  • 69. [Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol].
    Gill E; Bechler M; Forst HT
    ZFA (Stuttgart); 1980 May; 56(14):1037-44. PubMed ID: 7415470
    [No Abstract]   [Full Text] [Related]  

  • 70. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
    Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypertension in the elderly: treatment.
    Schulman SP; Gerstenblith G
    Cardiol Clin; 1986 May; 4(2):245-52. PubMed ID: 2871936
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Moducrin--a new combined preparation in the treatment of hypertension (author's transl)].
    Prachar H; Nobis H; Pollak H; Enenkel W
    Wien Klin Wochenschr; 1981 Aug; 93(15):489-92. PubMed ID: 7303690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 75. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 76. Serum potassium concentrations after initiation of captopril therapy.
    Schuna AA; Schmidt GR; Pitterle ME
    Clin Pharm; 1986 Nov; 5(11):920-3. PubMed ID: 3536269
    [No Abstract]   [Full Text] [Related]  

  • 77. [Short-term clinical trial of a clonidine-cyclothiazide combination in the treatment of arterial hypertension].
    Montini M; Sileo F
    Clin Ter; 1981 Feb; 96(4):383-92. PubMed ID: 7214861
    [No Abstract]   [Full Text] [Related]  

  • 78. [Clinical study of a combination of medical plants with antihypertensive action].
    Chaushev A; Stefanov G; Chakŭrski I; Koĭchev A
    Vutr Boles; 1981; 20(6):58-63. PubMed ID: 7039128
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical trial of an antihypertensive agent: antipressin].
    Warembourg H; Théry C
    Lille Med; 1967 Feb; 12(2):Suppl:143-6. PubMed ID: 5623385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.